We have previously shown in breast cancer cells that Orai3 silencing suppressed cell proliferation, arrested cell cycle in the G0/G1 phase, and this phenomenon is associated with a reduction in CDKs 4/2 and cyclins D1 and E expression. Here, ORAI3 is linked to breast carcinoma.